GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (TSXV:TELO) » Definitions » Additional Paid-In Capital

Telo Genomics (TSXV:TELO) Additional Paid-In Capital : C$6.10 Mil(As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Telo Genomics Additional Paid-In Capital?


Telo Genomics's quarterly additional paid-in capital increased from Jun. 2023 (C$6.00 Mil) to Sep. 2023 (C$6.04 Mil) and increased from Sep. 2023 (C$6.04 Mil) to Dec. 2023 (C$6.10 Mil).

Telo Genomics's annual additional paid-in capital increased from Jun. 2021 (C$5.64 Mil) to Jun. 2022 (C$5.80 Mil) and increased from Jun. 2022 (C$5.80 Mil) to Jun. 2023 (C$6.00 Mil).

Telo Genomics Additional Paid-In Capital Historical Data

The historical data trend for Telo Genomics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics Additional Paid-In Capital Chart

Telo Genomics Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.09 5.57 5.64 5.80 6.00

Telo Genomics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.87 5.91 6.00 6.04 6.10

Telo Genomics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Telo Genomics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Telo Genomics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Telo Genomics (TSXV:TELO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (TSXV:TELO) » Definitions » Additional Paid-In Capital
Comparable Companies
XCNQ:SONA TSXV:AVCR XCNQ:IZO XCNQ:BUX TSXV:ARC TSX:SZLS TSXV:JUMP XCNQ:VTAL NEOE:MEDV TSXV:MBI.H TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
TDSGF:USA 3D0A:Germany
Address
101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7
Website
https://www.telodx.com
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

Telo Genomics (TSXV:TELO) Headlines

From GuruFocus

UPDATE -- Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

By GlobeNewswire • 03-29-2024